Rose Blackburne, MD, MBA, is Vice President and Global Head of Women’s Health/General Medicine at PPD, a part of Thermo Fisher Scientific. Based in the Washington, DC area, Dr. Blackburne is board certified in Obstetrics/Gynecology with over 25 years of experience in healthcare, including 17 years in clinical research. Dr. Blackburne is a globally recognized leader in product development and has been instrumental in numerous approvals for pharmaceuticals, vaccines, medical devices, and diagnostic tests. Since 2016, Dr. Blackburne has served as Industry Representative Alternate to the FDA Patient Engagement Advisory Committee (PEAC) part of FDA’s Patient Focused Drug Development initiatives, to provide advice on issues relating to the regulation of medical devices and their use by patients and to develop Agency guidance and policies.